SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002725
Filing Date
2019-04-30
Accepted
2019-04-30 07:16:23
Documents
7
Period of Report
2019-06-18
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238676zdef14a.htm DEF 14A 1010678
2 G348071.JPG g348071.jpg GRAPHIC 16120
3 G181137.JPG g181137.jpg GRAPHIC 5277
4 G781497.JPG g781497.jpg GRAPHIC 112722
5 G263057.JPG g263057.jpg GRAPHIC 84548
6 G26542BGI001.GIF g26542bgi001.gif GRAPHIC 115421
7 G26542BGI002.GIF g26542bgi002.gif GRAPHIC 93723
  Complete submission text file 0001047469-19-002725.txt   1601733
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36306 | Film No.: 19778405
SIC: 2834 Pharmaceutical Preparations